Cargando…
Drug-device combinations for chronic diseases /
This book covers two areas, the first detailing the concepts and technologies of drug-device combination products. The second area includes case studies of important products that either significantly shape our technologies and thinking, or contribute to current healthcare practice. The book: -Discu...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken :
John Wiley & Sons,
2015.
|
| Edición: | 1st |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn948791311 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 141119s2015 nju o 000 0 eng d | ||
| 040 | |a NLE |b eng |e rda |e pn |c NLE |d OCLCO |d OCLCF |d OCLCO |d OCLCQ |d EBLCP |d OCLCO |d RECBK |d OCLCQ |d UKMGB |d OCLCO |d LOA |d K6U |d OCL |d OCLCQ |d OCLCO |d OCLCL | ||
| 015 | |a GBB4F3953 |2 bnb | ||
| 016 | 7 | |a 016991672 |2 Uk | |
| 020 | |a 9781119002970 |q (ePub ebook) | ||
| 020 | |a 1119002974 |q (ePub ebook) | ||
| 020 | |a 9781119003007 |q (PDF ebook) | ||
| 020 | |a 1119003008 |q (PDF ebook) | ||
| 029 | 1 | |a UKMGB |b 016991672 | |
| 035 | |a (OCoLC)948791311 | ||
| 037 | |a 9781119002970 |b Wiley | ||
| 050 | 4 | |a RS199.5 |b L987 2015 | |
| 082 | 0 | 4 | |a 615.19 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Lyu, SuPing, |e author. | |
| 245 | 1 | 0 | |a Drug-device combinations for chronic diseases / |c SuPing Lyu, Ronald Siegel. |
| 250 | |a 1st | ||
| 264 | 1 | |a Hoboken : |b John Wiley & Sons, |c 2015. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a CIP data; resource not viewed. | |
| 505 | 0 | |a Wiley -- Society for Biomaterials Series; Title Page; Copyright; Foreword; Preface; Part I: Backgrounds; Chapter 1: Addressing Medical Device Challenges With Drug-Device Combinations; 1.1 Introduction; 1.2 The Host Foreign Body Reaction; 1.3 Device-Based Thrombosis; 1.4 Biomaterials-Associated Infection; 1.5 Combination Medical Devices; 1.6 Future Directions; Acknowledgment; References; Chapter 2: Historical Survey of Drug Delivery Devices; 2.1 Introduction; 2.2 The Origins of Drug Delivery Devices; 2.3 Classification of Drug Delivery Devices. | |
| 505 | 8 | |a 2.4 An Early Example of Designed Drug Delivery Systems: Osmotic Drug Delivery Systems2.5 Another Early Delivery System Based on Membrane-Controlled Release: Ocular Delivery Systems; 2.6 EARLY SUCCESSES IN THE USE OF MEMBRANE AND HYBRID SYSTEMS: TRANSDERMAL PATCHES; 2.7 Early Efforts to Target Drug Delivery: Mucoadhesive Drug Delivery Systems; 2.8 Drug Delivery in Combination Products: Drug-Eluting Stents; 2.9 The Advent of Microfabricated Drug Delivery Devices; 2.10 Conclusions and Directions; References; Chapter 3: Development of Combination Product Drug Delivery Systems; 3.1 Introduction. | |
| 505 | 8 | |a 3.2 Oral Delivery3.3 Dermal Delivery; 3.4 Implantable Delivery; 3.5 Conclusions; Acknowledgments; References; Chapter 4: Drug-Material Interactions, Materials Selection, and Manufacturing Methods; 4.1 Introduction; 4.2 Drug-Device Interactions and Tests; 4.3 Material Selection and Development; 4.4 Manufacturing Methods for Combining Drugs into Devices; 4.5 Summary; References; Part II: Products; Chapter 5: Steroid-Releasing Lead; 5.1 Introduction; 5.2 Background; 5.3 The Quest for Low-Threshold Leads; 5.4 The Evolution of Steroid-Eluting Electrodes. | |
| 505 | 8 | |a 5.5 Inflammation Mechanisms and the Effects of Steroid Elution5.6 The Mechanism of Chronic Steroid Elution: Does the Steroid Run Out?; 5.7 Other Possible Drug Elution Systems; 5.8 Summary; References; Chapter 6: Thromboresistant Vascular Graft; 6.1 Introduction; 6.2 Vascular Grafting for Peripheral Arterial Reconstruction; 6.3 ePTFE Vascular Grafts; 6.4 Early Heparin Surfaces; 6.5 Carmeda Bioactive Surface Technology; 6.6 Understanding CBAS Surface Hemocompatibility; 6.7 Early Clinical Experience With CBAS Surface; 6.8 Product Development. | |
| 505 | 8 | |a 6.9 Clinical Performance, Clinical Usefulness, and Clinical Challenges6.10 Heparin-Induced Thrombocytopenia; 6.11 Working Hypothesis; 6.12 Summary; References; Chapter 7: Device-Enabled Drug Infusion Therapies; 7.1 Introduction; 7.2 Basic Device Requirements and Routes of Infusion; 7.3 Infusion Therapy Components and Functions; 7.4 Clinical Applications; 7.5 Advantages; 7.6 Interactions; 7.7 Challenges; 7.8 Development and Regulatory Approval of New Infusion Therapies; 7.9 New Indications in Development; 7.10 Future Possibilities for Infusion Technology; References. | |
| 520 | |a This book covers two areas, the first detailing the concepts and technologies of drug-device combination products. The second area includes case studies of important products that either significantly shape our technologies and thinking, or contribute to current healthcare practice. The book: -Discusses where drugs and devices work, where they fail, and when they need to work with each other -Reviews interactions between human bodies and the drug-device combination products the measurements of these interactions -Covers how a drug-device combination product is developed, tested, and regulated -Includes case studies of steroid releasing leads, AOA treated tissue heart valves, intrathecal drug delivery pumps, infuse bone grafts, drug eluting stents, and antimicrobial meshes. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Drug development. | |
| 650 | 0 | |a Drug delivery devices. | |
| 650 | 0 | |a Chronic diseases |x Treatment. | |
| 650 | 0 | |a Drugs |x Equipment and supplies. | |
| 650 | 6 | |a Médicaments |x Développement. | |
| 650 | 6 | |a Médicaments |x Administration |x Dispositifs. | |
| 650 | 6 | |a Maladies chroniques |x Traitement. | |
| 650 | 7 | |a TECHNOLOGY & ENGINEERING |x Materials Science. |2 bisacsh | |
| 650 | 7 | |a Drugs |x Equipment and supplies |2 fast | |
| 650 | 7 | |a Chronic diseases |x Treatment |2 fast | |
| 650 | 7 | |a Drug delivery devices |2 fast | |
| 650 | 7 | |a Drug development |2 fast | |
| 700 | 1 | |a Siegel, Ronald, |e author. | |
| 758 | |i has work: |a Drug-device combinations for chronic diseases (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFHxVdJCH7Tw8CWwYkMJTb |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4547687 |z Texto completo |
| 936 | |a BATCHLOAD | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4547687 | ||
| 938 | |a Recorded Books, LLC |b RECE |n rbeEB00665981 | ||
| 994 | |a 92 |b IZTAP | ||